Originally developed in the United States and now gaining momentum in the UK, Focused Research Organisations (FROs) represent an exciting new approach to organising science around ambitious, mission-driven objectives. Their purpose is not to generate shareholder value or individual academic accolades, but to create the tools, technologies, datasets and infrastructure that accelerate progress across entire scientific fields.

As someone working closely with emerging research organisations and innovative life science companies every day, I see FROs having the potential to become one of the most significant additions to the scientific ecosystem in decades.

One of the recurring challenges I see across the life sciences sector is that some of the most valuable scientific projects lack a natural home.

Academic institutions are incentivised to pursue novel discoveries and publish findings. Commercial organisations are incentivised to generate financial returns. Yet many of the foundational technologies and research platforms required to unlock future breakthroughs fall somewhere between these two environments.

These challenges often involve creating large-scale datasets, developing enabling technologies, building shared research infrastructure or solving complex engineering problems that could benefit thousands of researchers but may never become standalone businesses.

Recently, I’ve been looking into the FRO model and chatting with my network to understand the model and its potential to provide a mechanism to address these types of challenges. This exciting new model is looking like the opportunity to home in on for research that otherwise would be dismissed because it's too expensive, or that requires too much resource, and the outcomes are not time-bound enough.

To me, this captures the essence of the FRO model. FROs are deliberately designed to tackle scientific bottlenecks that are universally recognised as important, but for which no existing organisational structure is ideally suited.

Most FROs are established with a lifespan of approximately five years, a clearly defined mission and funding secured from the outset.

What makes them particularly interesting is the way they are organised. Rather than adopting a conventional academic structure, FROs operate much more like mission-led companies. Scientists work alongside engineers, computational specialists, project managers and operational experts, all aligned around a common objective.

From my perspective, their startup-like structure is one of the model's greatest strengths. It enables teams to recruit specialist expertise quickly, make decisions efficiently and maintain relentless focus on delivery. However, unlike startups, success is not measured through acquisition or commercial exit. Instead, success is defined by the creation of public goods that enable future scientific discovery.

The typical outputs from FROs currently being seen include:

• Open datasets

• New research tools

• Experimental platforms

• Scientific infrastructure

• Shared technologies

• Industry standards

The common thread being that the outputs are intended for broad use across the scientific community.

One of the simplest ways to understand an FRO is to consider where it sits within the innovation landscape.

Academic laboratories are exceptionally effective at generating new knowledge. Companies are highly effective at commercialising technology and bringing products to market. Between those two stages, however, there is often a critical development gap. This is where FROs can thrive.

During my conversations, FROs have been described as organisations that undertake the essential "middle-stage enabling" work required to convert promising scientific ideas into practical capabilities. Using the development of mRNA vaccines as an example, years of fundamental research and work were performed before this area of science was deployable at scale.

For me, this is one of the most compelling aspects of the model. FROs provide a mechanism for addressing scientific challenges that are critical to future innovation but often overlooked because they do not fit traditional funding or commercial frameworks.

Perhaps the most powerful aspect of the FRO model is that success extends far beyond the organisation itself. Rather than creating proprietary assets, FROs create shared resources that reduce barriers for everyone working in a field. This makes FROs particularly attractive for researchers and funders who are motivated by ecosystem-level impact and long-term scientific advancement.

While the FRO model originated in the US, the UK is becoming an important proving ground for its international expansion. With two of the UK's most prominent FROs currently based at LBIC, we are excited to be supporting these organisations and to be helping to raise awareness of this new way of doing science. We are already seeing first-hand the potential of this approach to reshape how ambitious scientific challenges are tackled.

The FRO model is still young. But based on what I have seen so far, if its early success is any indication, Focused Research Organizations may become one of the most important additions to the scientific ecosystem in decades. If you want to find out more about the FRO model, I’d suggest visiting Convergent Research as a good starting point.